Why Vaxcyte, Inc. (PCVX) stock moved
Vaxcyte, Inc. (PCVX) shares rose 0.2% to $59.02 as of September 23, 2026, a slight gain from the prior close of $58.92. BestStocks flagged the session as a major change for PCVX. Below, we break down what changed for PCVX, why it matters for investors, how the stock reacted, and the catalysts on the calendar.
PCVX climbed 0.2% to $59.02
PCVX rose 0.2% in its latest session, moving from $58.92 to $59.02.
What it means for Vaxcyte, Inc. investors
For Vaxcyte, Inc. investors, the recent signals are mixed, leaving the near-term picture neutral / mixed. On the constructive side: Positive 0.2% session move; PCVX moved +6.74% from its $55.17 open to a $58.89 close on 2026-08-06. Weighing against that: Vaxcyte, Inc. (PCVX) moved -3.07% from $59.91 to $58.07 on 2026-08-07; Vaxcyte, Inc. (PCVX) moved -3.51% from $58.04 to $56.00 on 2026-07-22. Wall Street's consensus price target sits at $105.57, implying +78.9% upside from $59.02. BestStocks rates the overall signal quality weak (34/100). With earnings roughly 41 days out, the next report is the most likely near-term test of the move.
PCVX price reaction
PCVX last traded at $59.02, up $0.10 (+0.17%) from the previous close of $58.92. The session traded on 0.9× average volume (below avg), so participation was unremarkable. Over the past month the stock has ranged between $58.13 and $61.87, and it currently sits about 24% of the way up that band.
Bullish and bearish analyst opinions on Vaxcyte, Inc. (PCVX)
The consensus analyst price target on Vaxcyte, Inc. (PCVX) is $105.57, 78.9% above the recent $59.02. Here is how the bullish and bearish cases on PCVX line up.
The bullish case
- Wall Street's consensus price target of $105.57 implies +78.9% upside from $59.02.
- The Street's most bullish target is $163.00 (+176.2%).
- Positive 0.2% session move.
- PCVX moved +6.74% from its $55.17 open to a $58.89 close on 2026-08-06.
- Vaxcyte, Inc. (PCVX) moved +4.58% from $55.50 to $58.04 on 2026-07-21.
The bearish case
- The most bearish analyst target is $58.00 (-1.7%).
- Vaxcyte, Inc. (PCVX) moved -3.07% from $59.91 to $58.07 on 2026-08-07.
Weighing both sides, BestStocks' composite read of recent signals is roughly balanced, as the bull-versus-bear meter above shows. This is an educational summary of the bull and bear case, not investment advice.
Analyst price targets and ratings are FMP consensus figures as of Sep 23, 2026; other aggregators may differ. High and low targets show the range of estimates, not forecasts.
Previous notable changes for PCVX
Frequently asked questions about PCVX
Why did Vaxcyte, Inc. (PCVX) stock move?
PCVX rose 0.2% to $59.02. No single company-specific catalyst was confirmed during the move window, and it looks technical.
How much did PCVX stock rise?
PCVX gained 0.17% ($0.10) versus the prior close of $58.92, last trading at $59.02 on 0.9× average volume.
When is Vaxcyte, Inc.'s next earnings date?
PCVX's next earnings report is estimated for 2026-11-03 — about 41 days away.
What is the analyst price target for PCVX?
The consensus analyst price target for PCVX is $105.57, about 78.9% above the current $59.02. Over the past 90 days, analysts recorded 0 upgrades, 0 maintains, and 0 downgrades.
How BestStocks tracks PCVX
This page is generated automatically by BestStocks' change-detection system after its price and volume cleared PCVX-specific materiality thresholds, triggering an evidence check. It draws on 20 tracked change events for PCVX, cross-checked against the data sources listed below. Price, volume, and market-capitalization figures are the live intraday quote as of September 23, 2026 and refresh as new information is detected; for companies with multiple share classes, market-cap figures can differ by data source. Analyst price targets and ratings are FMP consensus. This is an educational summary of what changed and why — not personalized investment advice.